Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Return on Capital Employed (2022 - 2025)

Envoy Medical's Return on Capital Employed history spans 4 years, with the latest figure at 389.22% for Q3 2025.

  • For Q3 2025, Return on Capital Employed fell 41487.0% year-over-year to 389.22%; the TTM value through Sep 2025 reached 389.22%, down 41487.0%, while the annual FY2024 figure was 8.14%, 1795.0% down from the prior year.
  • Return on Capital Employed for Q3 2025 was 389.22% at Envoy Medical, down from 9.19% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 53.94% in Q2 2024 and bottomed at 389.22% in Q3 2025.
  • The 4-year median for Return on Capital Employed is 1.6% (2023), against an average of 29.12%.
  • The largest annual shift saw Return on Capital Employed soared 5422bps in 2024 before it crashed -41487bps in 2025.
  • A 4-year view of Return on Capital Employed shows it stood at 0.04% in 2022, then crashed by -5917bps to 2.46% in 2023, then plummeted by -167bps to 6.58% in 2024, then crashed by -5818bps to 389.22% in 2025.
  • Per Business Quant, the three most recent readings for COCH's Return on Capital Employed are 389.22% (Q3 2025), 9.19% (Q2 2025), and 5.79% (Q1 2025).